An in-depth analysis of Nigeria's pharmaceutical manufacturing landscape, examining the impact of the Executive Order on Health Value Chains, the rise of API production, and the strategic roadmap to achieve 70% local production capacity by 2027.
A comprehensive guide for Nigerian pharmacists on leveraging AI technologies—from drug discovery to patient care. Learn about AI-powered medication management, clinical decision support systems, and practical implementation strategies.
A detailed explanation of NAFDAC's regulatory framework designed to boost local pharmaceutical manufacturing. Learn how the 5+5 moratorium and Ceiling List are reshaping Nigeria's drug production landscape.
A comprehensive analysis of the malaria vaccine rollout across Nigeria. Understand the differences between RTS,S and R21 vaccines, pharmacy's role in immunization programs, and the impact on malaria prevention strategies.
Explore diverse career opportunities in Nigeria's growing pharmaceutical manufacturing sector. From production and quality assurance to regulatory affairs and R&D, discover how to build a successful career as an industrial pharmacist.
FDA granted approvals for Desmoda (diabetes insipidus), Yuviwel (achondroplasia), and Loargys (arginase deficiency). Dupixent became first approved therapy for allergic fungal rhinosinusitis in pediatric patients.
CHMP recommended mCombriax as Europe's first combined influenza and COVID-19 mRNA vaccine for adults 50+. Uplizna approved for generalized myasthenia gravis with twice-yearly dosing.
FDA approvals for AI-enabled medical devices surpass 1,200. Agentic AI systems now handling complex pharmacy workflows, care coordination, and clinical decision support. AI scribes reducing physician burnout by 31%.
President Trump signed the Consolidated Appropriations Act 2026. PBMs must now 'delink' compensation from drug rebates in Medicare Part D and pass through 100% of rebates to plan sponsors by January 2028.
At the 2026 NAIP Economic Outlook Forum, Emir of Kano and Obi of Onitsha called for acceleration toward 70% local production. Currently 70% of drugs are imported, with 82% from India.
An in-depth analysis of Nigeria's pharmaceutical manufacturing landscape, examining the impact of the Executive Order on Health Value Chains, the rise of API production, and the strategic roadmap to achieve 70% local production capacity by 2027.
A comprehensive guide for Nigerian pharmacists on leveraging AI technologies—from drug discovery to patient care. Learn about AI-powered medication management, clinical decision support systems, and practical implementation strategies.
A detailed explanation of NAFDAC's regulatory framework designed to boost local pharmaceutical manufacturing. Learn how the 5+5 moratorium and Ceiling List are reshaping Nigeria's drug production landscape.
A comprehensive analysis of the malaria vaccine rollout across Nigeria. Understand the differences between RTS,S and R21 vaccines, pharmacy's role in immunization programs, and the impact on malaria prevention strategies.
Explore diverse career opportunities in Nigeria's growing pharmaceutical manufacturing sector. From production and quality assurance to regulatory affairs and R&D, discover how to build a successful career as an industrial pharmacist.
FDA granted approvals for Desmoda (diabetes insipidus), Yuviwel (achondroplasia), and Loargys (arginase deficiency). Dupixent became first approved therapy for allergic fungal rhinosinusitis in pediatric patients.
CHMP recommended mCombriax as Europe's first combined influenza and COVID-19 mRNA vaccine for adults 50+. Uplizna approved for generalized myasthenia gravis with twice-yearly dosing.
FDA approvals for AI-enabled medical devices surpass 1,200. Agentic AI systems now handling complex pharmacy workflows, care coordination, and clinical decision support. AI scribes reducing physician burnout by 31%.
President Trump signed the Consolidated Appropriations Act 2026. PBMs must now 'delink' compensation from drug rebates in Medicare Part D and pass through 100% of rebates to plan sponsors by January 2028.
At the 2026 NAIP Economic Outlook Forum, Emir of Kano and Obi of Onitsha called for acceleration toward 70% local production. Currently 70% of drugs are imported, with 82% from India.
The Nigeria Academy of Pharmacy exists to advance pharmaceutical knowledge and strengthen the role of pharmacy in national development.
To harness the collective expertise of Fellows to advance pharmaceutical knowledge, promote excellence and ethics, mentor the next generation, and strengthen Nigeria's health systems through strategic partnerships.
To be the leading catalyst for pharmaceutical knowledge, innovation, and leadership in Nigeria and Africa, advancing health, industry, and national development.
Highest standards in knowledge and practice
Ethical responsibility and public trust
Creativity and digital transformation
Cross-sector partnerships
Over a decade of strategic leadership driving pharmaceutical excellence in Nigeria
Guiding NAPharm's mission to position pharmacy as a driver of national health security and economic diversification
Shaping pharmaceutical education, practice, and regulation through research, policy briefs, and heritage preservation.
Setting benchmarks for ethical and scientific excellence through CPD, standards, and competency frameworks.
Building a pipeline of innovative, globally competitive pharmacists through structured mentorship programs.
Championing medicine security, patient safety, and public health engagement across Nigeria.
Forging strategic alliances with FIP, WHO, AMA, and leveraging AfCFTA for regional pharmaceutical growth.
Comprehensive programs driving pharmaceutical excellence across education, research, and practice
Pharm.D programs, postgraduate training, and continuing professional development.
Setting benchmarks for ethical, professional, and scientific excellence in pharmacy.
Advancing pharmaceutical research, innovation, and indigenous product development.
Championing regulatory reforms and medicine security for Nigeria.
Nurturing future pharmacists and healthcare leaders through structured mentorship.
Promoting public health literacy and pharmacists' role in primary care.
Join us at our upcoming events, conferences, and webinars
Valuable resources, insights, and publications from the industry
Exploring how structured mentorship programs can shape the next generation of pharmaceutical leaders in Nigeria.
An in-depth look at regulatory reforms needed to strengthen pharmacy practice standards.
NAPharm's strategic initiatives are reshaping the pharmaceutical landscape in Nigeria.